Literature DB >> 11934977

Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs.

P Airò, C M Antonioli, M Vianelli, P Toniati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11934977     DOI： 10.1093/rheumatology/41.3.347

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  11 in total

Review 1.  New indications for biological therapies.

Authors:  Mariagrazia Catanoso; Nicolò Pipitone; Luca Magnani; Luigi Boiardi; Carlo Salvarani
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  Treatment of refractory temporal arteritis with adalimumab.

Authors:  M Mubashir Ahmed; Eisha Mubashir; Samina Hayat; Marjorie Fowler; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-08-30       Impact factor: 2.980

Review 3.  Diagnosis and treatment of giant cell arteritis.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Michele Bertoni; Carlo Salvarani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Biologic Therapy for the Treatment of Giant Cell Arteritis.

Authors:  Rochella A Ostrowski; Melissa R Bussey; Rodney Tehrani; Walter Jay
Journal:  Neuroophthalmology       Date:  2014-04-02

5.  Successful treatment of refractory giant cell arteritis with etanercept.

Authors:  Masaaki Fujita; Yuya Tabuchi; Masato Yagita
Journal:  Rheumatol Int       Date:  2016-07-01       Impact factor: 2.631

Review 6.  Advances in the use of biologic agents for the treatment of systemic vasculitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

7.  Giant Cell Arteritis.

Authors:  Jennifer K. Hall; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

8.  Headache Caused by Giant Cell Arteritis.

Authors:  Thomas N Ward; Morris Levin; Robert L Wong
Journal:  Curr Treat Options Neurol       Date:  2004-11       Impact factor: 3.598

9.  TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.

Authors:  So Jin Lee; Aeju Lee; Seung Rim Hwang; Jong-Sung Park; Jiyeon Jang; Myung Sook Huh; Dong-Gyu Jo; Soo-Young Yoon; Youngro Byun; Sun Hwa Kim; Ick Chan Kwon; Inchan Youn; Kwangmeyung Kim
Journal:  Mol Ther       Date:  2013-10-22       Impact factor: 11.454

Review 10.  Horton's disease: past and present.

Authors:  Morris Levin; Thomas N Ward
Journal:  Curr Pain Headache Rep       Date:  2005-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.